|
1
|
Yoysungnoen B, Bhattarakosol P, Changtam C
and Patumraj S: Effects of tetrahydrocurcumin on tumor growth and
cellular signaling in cervical cancer xenografts in nude mice.
Biomed Res Int. 2016:17812082016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin WC, Kuo KL, Shi CS, Wu JT, Hsieh JT,
Chang HC, Liao SM, Chou CT, Chiang CK, Chiu WS, et al: MLN4924, a
Novel NEDD8-activating enzyme inhibitor, exhibits antitumor
activity and enhances cisplatin-induced cytotoxicity in human
cervical carcinoma: In vitro and in vivo study. Am J Cancer Res.
5:3350–3362. 2015.PubMed/NCBI
|
|
4
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, et al:
Cervical cancer. J Natl Compr Canc Netw. 11:320–343. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma X, Zhang J, Liu S, Huang Y, Chen B and
Wang D: Nrf2 knockdown by shRNA inhibits tumor growth and increases
efficacy of chemotherapy in cervical cancer. Cancer Chemother
Pharmacol. 69:485–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dreyfuss G, Kim VN and Kataoka N:
Messenger-RNA-binding proteins and the messages they carry. Nat Rev
Mol Cell Biol. 3:195–205. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kozu T, Henrich B and Schäfer KP:
Structure and expression of the gene (HNRPA2B1) encoding the human
hnRNP protein A2/B1. Genomics. 25:365–371. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He Y, Brown MA, Rothnagel JA, Saunders NA
and Smith R: Roles of heterogeneous nuclear ribonucleoproteins A
and B in cell proliferation. J Cell Sci. 118:3173–3183. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patry C, Bouchard L, Labrecque P, Gendron
D, Lemieux B, Toutant J, Lapointe E, Wellinger R and Chabot B:
Small interfering RNA-mediated reduction in heterogeneous nuclear
ribonucleoparticule A1/A2 proteins induces apoptosis in human
cancer cells but not in normal mortal cell lines. Cancer Res.
63:7679–7688. 2003.PubMed/NCBI
|
|
10
|
Izaurralde E, Jarmolowski A, Beisel C,
Mattaj IW, Dreyfuss G and Fischer U: A role for the M9 transport
signal of hnRNP A1 in mRNA nuclear export. J Cell Biol. 137:27–35.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Y and Smith R: Nuclear functions of
heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci.
66:1239–1256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kamma H, Horiguchi H, Wan L, Matsui M,
Fujiwara M, Fujimoto M, Yazawa T and Dreyfuss G: Molecular
characterization of the hnRNPA2/B1 proteins: Tissue-specific
expression and novel isoforms. Exp Cell Res. 246:399–411. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu XH, Liu JL, Zhong XW, Li XI and Zhang
QG: Insights into the roles of hnRNP A2/B1 and AXL in non-small
cell lung cancer. Oncol Lett. 10:1677–1685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Joshi J, Fernandez-Marcos PJ, Galvez A,
Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M,
Collado M, et al: Par-4 inhibits Akt and suppresses Ras-induced
lung tumorigenesis. EMBO J. 27:2181–2193. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang M, Fang X, Liu H, Guo R, Wu X, Li B,
Zhu F, Ling Y, Griffith BN, Wang S and Yang D: Bioinformatics-based
discovery and characterization of an AKT-selective inhibitor
9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer
cells. Cancer Lett. 252:244–258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao N, Flynn DC, Zhang Z, Zhong XS, Walker
V, Liu KJ, Shi X and Jiang BH: G1 cell cycle progression and the
expression of G1 cyclins are regulated by PI3K/AKT/mTOR/P70S6KI
signaling in human ovarian cancer cells. Am J Physiol Cell Physiol.
287:C281–C291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Ran L, Fang W and Wang D: Lobaplatin
arrests cell cycle progression, induces apoptosis and alters the
proteome in human cervical cancer cell line CaSki. Biomed
Pharmacother. 68:291–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jang HJ, Hong EM and Lee J, Choi JE, Park
SW, Byun HW, Koh DH, Choi MH, Kae SH and Lee J: Synergistic effects
of simvastatin and Irinotecan against colon cancer cells with or
without Irinotecan resistance. Gastroenterol Res Pract.
2016:78913742016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kodawara T, Higashi T, Negoro Y, Kamitani
Y, Igarashi T, Watanabe K, Tsukamoto H, Yano R, Masada M, Iwasaki H
and Nakamura T: The inhibitory effect of Ciprofloxacin on the
β-Glucuronidase-mediated deconjugation of the Irinotecan metabolite
SN-38-G. Basic Clin Pharmacol Toxicol. 118:333–337. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren C, Ren T, Yang K, Wang S, Bao X, Zhang
F and Guo W: Inhibition of SOX2 induces cell apoptosis and G1/S
arrest in Ewing's sarcoma through the PI3K/Akt pathway. J Exp Clin
Cancer Res. 35:442016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Golan-Gerstl R, Cohen M, Shilo A, Suh SS,
Bakàcs A, Coppola L and Karni R: Splicing factor hnRNPA2/B1
regulates tumor suppressor gene splicing and is an oncogenic driver
in glioblastoma. Cancer Res. 7:4464–4472. 2011. View Article : Google Scholar
|
|
23
|
Shilo A, Ben Hur V, Denichenko P, Stein I,
Pikarsky E, Rauch J, Kolch W, Zender L and Karni R: Splicing factor
hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf
splicing in hepatocellular carcinoma development. RNA. 20:505–515.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
David CJ, Chen M, Assanah M, Canoll P and
Manley JL: hnRNP proteins controlled by c-Myc deregulate pyruvate
kinase mRNA splicing in cancer. Nature. 463:364–368. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao CH, Li QF, Chen LY, Tang J, Song JY
and Xie Z: Expression and localization of hnRNP A2/B1 during
differentiation of human osteosarcoma MG-63 cells induced by HMBA.
Ai Zheng. 27:677–684. 2008.(In Chinese). PubMed/NCBI
|
|
26
|
Katsimpoula S, Patrinou-Georgoula M,
Makrilia N, Dimakou K, Guialis A, Orfanidou D and Syrigos KN:
Overexpression of hnRNPA2/B1 in bronchoscopic specimens: A
potential early detection marker in lung cancer. Anticancer Res.
29:1373–1382. 2009.PubMed/NCBI
|
|
27
|
Etcheverry GJ: 2006 Nobel prize in
physiology or medicine. The silence of genes. Medicina (B Aires).
67:92–95. 2007.PubMed/NCBI
|
|
28
|
Sinha P, Poland J, Kohl S, Schnölzer M,
Helmbach H, Hütter G, Lage H and Schadendorf D: Study of the
development of chemoresistance in melanoma cell line using proteome
analysis. Electrophoresis. 24:2386–2404. 2013. View Article : Google Scholar
|
|
29
|
Bologna-Molina R, Mosqueda-Taylor A,
Molina-Frechero N, Mori-Estevez AD and Sánchez-Acuña G: Comparison
of the value of PCNA and Ki67 as markers of cell proliferation in
ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 18:e174–e179.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cotrim P, Martelli-Junior H, Graner E,
Sauk JJ and Coletta RD: Cyclosporin A induces proliferation in
human gingival fibroblasts via induction of transforming growth
factor-beta1. Periodontol. 74:1625–1633. 2003. View Article : Google Scholar
|
|
31
|
Stanley G, Harvey K, Slivova V, Jiang J
and Sliva D: Ganoderma lucidum suppresses angiogenesis through the
inhibition of secretion of VEGF and TGF-beta1 from prostate cancer
cells. Biochem Biophys Res Commun. 330:46–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clower CV, Chatterjee D, Wang Z, Cantley
LC, Vander Heiden MG and Krainer AR: The alternative splicing
repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform
expression and cell metabolism. Proc Nati Acad Sci USA. 107:pp.
1894–1899. 2010; View Article : Google Scholar
|
|
33
|
Gu WJ and Liu HL: Induction of pancreatic
cancer cell apoptosis, invasion, migration, and enhancement of
chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by
hnRNP A2/B1 siRNA. Anticancer Drugs. 24:566–576. 2013.PubMed/NCBI
|
|
34
|
Tauler J, Zudaire E, Liu H, Shih J and
Mulshine JL: hnRNP A2/B1 modulates epithelial-mesenchymal
transition in lung cancer cell lines. Cancer Res. 70:7137–7147.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Liu HL, Li Y and Yuan P: Proteomic
analysis of pancreatic intraepithelial neoplasia and pancreatic
carcinoma in rat models. World J Gastroenterol. 17:1434–1441. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hallett RM, Huang C, Motazedian A, Auf der
Mauer S, Pond GR, Hassell JA, Nordon RE and Draper JS:
Treatment-induced cell cycle kinetics dictate tumor response to
chemotherapy. Oncotarget. 6:7040–7052. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Montague JW and Cidlowski JA: Cellular
catabolism in apoptosis: DNA degradation and end nuclease
activation. Experientia. 52:857–862. 1996. View Article : Google Scholar
|
|
38
|
Zhu D, Xu G, Ghandhi S and Hubbard K:
Modulation of the expression of p16INK4a and p14AKT by hnRNPA1 and
A2 RNA binding proteins: Implications for cellular senescence. J
Cell Physiol. 193:19–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chu I, Sun J, Arnaout A, Kahn H, Hanna W,
Narod S, Sun P, Tan CK, Hengst L and Slingerland J: p27
phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell.
128:281–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li
ZH, Liu XD, Wang SG, Bie P, Jiang P, et al: Fyn requires hnRNPA2/B1
and Sam68 to synergistically regulate apoptosis in pancreatic
cancer. Carcinogenesis. 32:1419–1426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zimmermann KC, Bonzon C and Green DR: The
machinery of programmed cell death. Pharmacol Ther. 92:57–70. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stegeman H, Span PN, Kaanders JH and
Bussink J: Improving chemoradiation efficacy by PI3-K/AKT
inhibition. Cancer Treat Rev. 40:1182–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Manning BD and Cantley LC: AKT/PKB
Signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tsai JP, Lee CH, Ying TH, Lin CL, Hsueh JT
and Hsieh YH: Licochalcone A induces autophagy through
PI3K/Akt/mTOR inactivation and autophagy suppression enhances
Licochalcone A-induced apoptosis of human cervical cancer cells.
Oncotarget. 6:28851–28866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Choi HS, Lee HM, Jang YJ, Kim CH and Ryu
CJ: Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the
self-renewal and pluripotency of human embryonic stem cells via the
control of the G1/S transition. Stem Cells. 31:2647–2658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
